Medication Guide App

Anthelban V

This page contains information on Anthelban V for veterinary use.
The information provided typically includes the following:
  • Anthelban V Indications
  • Warnings and cautions for Anthelban V
  • Direction and dosage information for Anthelban V

Anthelban V

This treatment applies to the following species:
Manufacturer: Clipper (Phoenix Pharm.)

(pyrantel pamoate)

Active Ingredient: 50 mg of pyrantel base as pyrantel pamoate per mL

Equine Anthelmintic Suspension

FOR ANIMAL USE ONLY

Pyrantel Pamoate Equine is a suspension of pyrantel pamoate in a palatable mint-flavored vehicle. Each mL contains 50 mg of pyrantel base as pyrantel pamoate.

Pyrantel pamoate is a compound belonging to a family classified chemically as tetrahydropyrimidines. It is a yellow, water-insoluble crystalline salt of the tetrahydropyrimidine base and pamoic acid containing 34.7% base activity. The chemical structure and name are given below:

(E)-1,4,5,6-Tetrahydro-1-methyl-2-[2-(2-thienyl) vinyl] pyrimidine 4, 4' methylenebis [3-hydroxy-2-naphthoate] (1:1)

Anthelban V Indications

For the removal and control of mature infections of large strongyles (Strongylus vulgaris, S. edentatus, S. equinus); pinworms (Oxyuris equi); large roundworms (Parascaris equorum); and small strongyles in horses and ponies.

Directions For Use

Pyrantel Pamoate Equine may be administered by means of a stomach tube, dose syringe or by mixing into the feed. Administer 3 mg pyrantel base per pound of body weight (6 mL Pyrantel Pamoate Equine per 100 lb body weight). It is recommended that severely debilitated animals not be treated with this preparation. For maximum control of parasitism, it is recommended that foals (2-8 months of age) be dosed every 4 weeks. To minimize potential hazard that the mare may pose to the foal, she should be treated 1 month prior to anticipated foaling date followed by retreatment 10 days to 2 weeks after birth of foal. Horses over 8 months of age should be routinely dosed every 6 weeks.

Stomach Tube - Measure the appropriate dosage of Pyrantel Pamoate Equine and mix in the desired quantity of water. Protect drench from direct sunlight and administer to the animal immediately following mixing. Do not attempt to store diluted suspension. Pyrantel Pamoate Equine is inactive against the common horse bot (Gastrophilus spp). However, Pyrantel Pamoate Equine may be administered concurrently with carbon disulfide observing the usual precautions with carbon disulfide.

Dose Syringe - Draw the appropriate dosage of Pyrantel Pamoate Equine into a dose syringe and administer to the animal. Do not expose Pyrantel Pamoate Equine to direct sunlight.

Feed - Mix the appropriate dosage of Pyrantel Pamoate Equine in the normal grain ration. Fasting of animals prior to or following treatment is not required.

Storage

Store at room temperature between 15°-30°C (59°-86°F). Keep container tightly closed when not in use.

Anthelban V Caution

THIS PRODUCT IS A SUSPENSION AND AS SUCH WILL SEPARATE. TO INSURE UNIFORM RE-SUSPENSION AND TO ACHIEVE PROPER DOSAGE, IT IS EXTREMELY IMPORTANT THAT THE PRODUCT BE SHAKEN AND STIRRED THOROUGHLY BEFORE EVERY USE.

Warning

Not for horses or ponies intended for food. Keep out of the reach of children.

SAFETY AND EFFICACY: Pyrantel Pamoate Equine is well tolerated by horses and ponies of all ages. Adverse drug response was not observed when dose rates up to 60 mg pyrantel base per lb of body weight were administered by stomach tube nor when 3 mg base per lb was given by intratracheal injection. The reproductive performance of pregnant mares and stud horses dosed with pyrantel pamoate suspension has not been affected. Critical (worm-count) studies in horses demonstrated that pyrantel pamoate suspension administered at the recommended dosage was efficacious against mature infections of Strongylus vulgaris (>90%), S. edentatus (69%), S. equinus (>90%), Oxyuris equi (81%), Parascaris equorum (>90%), and small strongyles (>90%).

Anthelban V Caution

Federal law restricts this drug to use by or on the order of a licensed veterinarian.

PRESENTATION: 16 fl oz (476 mL) and 32 fl oz (960 mL).

Manufactured By: FIRST PRIORITY, INC., Elgin, IL 60123-1146

ANADA 200-353, Approved by FDA

FOR ANIMAL USE ONLY

KEEP OUT OF REACH OF CHILDREN

PHOENIX™ PHARMACEUTICAL, INC.

Manufactured for: Clipper Distributing Company, LLC, St. Joseph, MO 64507

Iss. 12-03

Net Contents:

NDC

 

16 fl oz (473 mL)

57319-557-21

Iss. 06-09

32 fl oz (960 mL)

57319-557-22

Iss. 06-09

NAC No.: 1256007.10

CLIPPER DISTRIBUTING CO., LLC
PHOENIX PHARMACEUTICAL INC.

1302 SOUTH 59 STREET, ST. JOSEPH, MO, 64507
Telephone:   816-364-5777
Order Desk:   800-759-3644
Fax:   816-364-4969
Website:   www.clipperdist.net
Email:   info@clipperdist.net
Every effort has been made to ensure the accuracy of the Anthelban V information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the US product label or package insert.

Copyright © 2014 North American Compendiums. Updated: 2014-09-05

(web3)